CPT® Code 90623

The CPT® Code 90623 refers to the meningococcal pentavalent vaccine, which is designed to provide active, long-term immunity against meningococcal disease. This vaccine works by exposing the recipient's immune system to altered versions of specific pathogens, prompting the immune system to produce its own antibodies. This process enables the body to "remember" how to generate these antibodies upon future exposure to the same antigens. Meningococcal disease, although rare, poses a serious health risk as it can lead to infections of the brain, spinal cord, and bloodstream. Particularly concerning is the MenB strain, which can escalate rapidly and become fatal within a mere 24 hours, primarily affecting adolescents and young adults. The vaccine comprises two sterile components: the pentavalent MenACWY vaccine, which includes equal amounts of polysaccharides conjugated to a tetanus toxoid carrier, and the MenB component, which contains two recombinant lipidated FHbp variants. The MenACWY component is lyophilized for storage and is reconstituted with the MenB component prior to administration. It is important to note that this code specifically reports the vaccine product itself and does not encompass the percutaneous administration of the vaccine.